Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 4 Shares withheld for taxes Interim CEO gave up 242 shares (to pay taxes)
  2. 4 Shares withheld for taxes SVP of Finance gave up 94 shares (to pay taxes)
  3. 4 Open-market buy 10% owner bought 100 shares at $2.90 ($290)
  4. 4 Open-market buy 10% owner bought 100 shares at $3.50 ($350)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 8-K Event Executive or director change · Regulation FD disclosure
  8. 4 Shares withheld for taxes SVP of Finance gave up 95 shares (to pay taxes)
  9. 4 Shares withheld for taxes Interim CEO gave up 241 shares (to pay taxes)
  10. 10-Q Report Quarterly Report
  11. 4 Open-market buy 10% owner bought 881 shares at $3.15 ($2,776)
  12. 8-K Event Results of operations
  13. 4 Open-market buy 10% owner bought 302 shares at an average $3.09 ($934)
  14. 4 Open-market buy 10% owner bought 4,801 shares at an average $2.78 ($13,332)
  15. 4 Shares withheld for taxes Interim CEO gave up 241 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP of Finance gave up 94 shares (to pay taxes)
  17. 4 Open-market buy 10% owner bought 300 shares at $3.66 ($1,097)
  18. 4 Open-market buy 10% owner bought 100 shares at $3.67 ($367)
  19. 4 Open-market buy 10% owner bought 393 shares at an average $3.05 ($1,199)
  20. 4 Open-market buy 10% owner bought 300 shares at an average $3.50 ($1,051)

Page 27 of 77 · 1,525 filings